tirzepatide ending FDA ends GLP-1 compounding for semaglutide, Eli Lilly's $1 Trillion Boom:

Well be touching on some of the most important ones that have a well-researched scientific background to support their claims

Report side effects Nausea, vomiting, diarrhea, constipation, and abdominal discomfort can occur

For those using oral contraceptives , precautions depend on which weight loss medication you're taking: With semaglutide (Wegovy) or liraglutide (Saxenda): No routine additional contraception is required based on product information With tirzepatide: Use a non-oral contraceptive method or add barrier methods (condoms) for 4 weeks after starting treatment and for 4 weeks after each dose increase If you experience vomiting or diarrhoea while taking oral contraceptives: If you vomit within 3 hours of taking your pill, follow the missed pill guidance for your specific pill type If you have severe diarrhoea lasting more than 24 hours, follow missed pill guidance Consider emergency contraception if you've had unprotected intercourse during this time Barrier methods alone (condoms, diaphragms) remain unaffected by weight loss medications but have higher typical-use failure rates (1318%) and require consistent, correct use

No approved generic semaglutide or tirzepatide exists

Less common, but they're more sensitive to gastric emptying changes